Residual JeKo-1 cells recovered from BM and spleen had a conserved expression of CXCR5 in both CAR-T cell groups (Supplementary Fig. 11d), underlining that tumor recurrence was not a result of the selection for CXCR5 antigen loss variants. This evidence concerns the gene CXCR5 and neoplasm.